PT ESA Medika Mandiri Tbk
IIDX:EMMI410.00
IDR
-8.00
(-1.91%)
ISIN
ID1000214505
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Tangerang Indonesia
- IPO Date
- Jul 8, 2026
- Website
- esamedika.com
- Similar Companies
- Business
- PT ESA Medika Mandiri Tbk is an Indonesia-based healthcare equipment provider engaged in the wholesale distribution, domestic manufacturing, and after-sales servicing of medical, surgical, laboratory, and pharmaceutical devices. Founded in 2000 and headquartered in Tangerang, Banten, Indonesia, the company delivers integrated medical infrastructure solutions primarily catering to public and private hospitals, clinical laboratories, intensive care units, and healthcare facilities across Indonesia. The company's extensive product and service portfolio comprises operating theater systems, including hydraulic and electric operating tables under the Kronen brand, surgical lighting units, electrosurgical generators, and surgical instruments; critical care and life support equipment, including mechanical ventilators, anesthesia delivery systems, high-flow nasal cannula oxygen therapy devices, multi-parameter patient monitors, volumetric infusion pumps, and precision syringe pumps; diagnostic and laboratory instruments, including hematology analyzers, digital radiography X-ray systems, ultrasound machines, and electrocardiographs (ECG); central sterile supply department (CSSD) and infection control infrastructure, including autoclaves, washer-disinfectors, and high-vacuum suction units; maternal and infant care equipment, including obstetric delivery tables and infant warmers; surgical consumables and disposables, including surgical sutures and wound closure products; and lifecycle engineering services, including medical gas and room infrastructure design, equipment installation, clinical user training, preventative maintenance, safety calibration, and spare parts management in accordance with Good Medical Device Manufacturing Practice (CPAKB) and Good Medical Device Distribution Practice (CDAKB) standards. In recent developments, PT ESA Medika Mandiri Tbk completed its initial public offering (IPO) on the Indonesia Stock Exchange in July 2026 under the ticker symbol EMMI, issuing 522.857 million common shares and raising approximately IDR 269.27 billion in gross proceeds to reinforce working capital and accelerate operational scale. To support national healthcare localization initiatives and satisfy Indonesian domestic component level (TKDN) requirements, the company has expanded its manufacturing footprint with production facilities in Cikupa and Solo, alongside advancing its strategic joint venture with Weigao Group to manufacture surgical sutures and specialized medical consumables locally.